Cargando…
Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients
PURPOSE: The efficacy of post-surgery platinum-based chemotherapy, the primary choice for the treatment of ovarian cancer (OC), is greatly reduced by the development of drug-resistance. In this study, we investigated the association of expression low-density lipoprotein receptor (LDLR) and 3-hydroxy...
Autores principales: | Huang, Xueyao, Wei, Xuan, Qiao, Sijing, Zhang, Xue, Li, Rui, Hu, Shunxue, Mao, Hongluan, Liu, Peishu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664653/ https://www.ncbi.nlm.nih.gov/pubmed/34908877 http://dx.doi.org/10.2147/CMAR.S337873 |
Ejemplares similares
-
Statin-Induced Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (Anti-HMGCR) Myopathy
por: Ghazal, Fatima, et al.
Publicado: (2023) -
The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases
por: Friesen, Jon A, et al.
Publicado: (2004) -
A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus
por: Stormo, Camilla, et al.
Publicado: (2012) -
Hypercholesterolemia and 3-Hydroxy 3-Methylglutaryl Coenzyme A Reductase Regulation during Ageing
por: Trapani, Laura, et al.
Publicado: (2009) -
Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies
por: Musset, Lucile, et al.
Publicado: (2014)